Press release
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respiratory Diseases Propels Growth Of Inhalable Drug Market
Inhalable Drugs
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has been expanding robustly over the past few years. Its size is projected to rise from $35.06 billion in 2024 to $36.91 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historical period include a rise in the elderly population, a patient inclination towards non-invasive therapies, an amplified emphasis on respiratory health, and the growth of emerging markets.
Inhalable Drugs Market Size Forecast: What's the Projected Valuation by 2029?
The market for inhalable drugs is anticipated to witness robust growth in the coming years, expanding to "$49.17 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. The projected growth in this period can be linked to factors such as increased expenditure in healthcare, rising demand for biologics, a growing emphasis on personalized medicine, and regulatory encouragement for rare disease drugs. Noteworthy trends during the forecast period encompass the use of advanced respiratory drugs in animal healthcare, technological advancements, and enhancements in reimbursement policies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report
What Are the Drivers Transforming the Inhalable Drugs Market?
The surge in respiratory illnesses is predicted to boost the inhalable drug market's expansion in the future. Respiratory diseases, which encompass conditions affecting the lungs, bronchi, trachea, larynx, pharynx, and nasal passages, are a growing health concern. Inhalable medications play a vital role in treating various respiratory diseases by delivering drugs directly to the lungs. As per the Australian Bureau of Statistics in December 2023, it was reported that in 2022, 2.5% of the population, equating to 638,100 individuals, suffered from COPD in Australia, with nearly equal rates in men (2.4%) and women (2.6%). Current daily smokers showed a higher likelihood of COPD (8.1%) compared to former smokers (4.4%) and non-smokers (1.6%). Therefore, the rising incidence of respiratory diseases is set to fuel the inhalable drug market's growth in the future.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12490&type=smp
What Long-Term Trends Will Define the Future of the Inhalable Drugs Market?
Product innovation stands out as a significant trend that's catching on in the inhalable drug industry. Major players within this market are focusing on the progression of inhalable medications to maintain their market status. For illustration, in July 2022, the pharmaceutical company based in Germany, DMV-Fonterra Excipients GmbH & Co. KG, broadened its dry powder inhalation (DPI) array with the introduction of Lactohale 400. This recent upgrade is tailored to meet particular pharmaceutical company requests and is cooperatively developed with formulators to bolster patient results. The broad range of lactose-centered additions is intended to present suitable traits for different inhaled treatments. Lactohale 400 is a refined, dry lactose variety compatible with DPI applications that necessitate high flow and unity. Its non-water-containing property distinguishes it from commonly used lactose carriers, featuring different aerosolization performance from lactose monohydrate of the same particle size.
Which Segments in the Inhalable Drugs Market Offer the Most Profit Potential?
The inhalable drugs market covered in this report is segmented -
1) By Product: Aerosol, Dry Powder Formulation, Spray
2) By Distribution Channel: Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels
3) By Application: Respiratory Diseases, Non-Respiratory Diseases
4) By End Users: Adults, Pediatric, Geriatric
Subsegments:
1) By Aerosol: Metered Dose Inhalers (MDIs), Nebulizers, Soft Mist Inhalers
2) By Dry Powder Formulation: Dry Powder Inhalers (DPIs), Blister Packs, Capsules
3) By Spray: Nasal Sprays, Oral Sprays, Subcutaneous Sprays
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12490&type=smp
Which Firms Dominate the Inhalable Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the inhalable drugs market include Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Catalent Inc., Sumitomo Pharma Co. Ltd., Intertek Group plc, AptarGroup Inc., Cipla Inc., Glenmark Pharmaceuticals Inc., Piramal Pharma Ltd., Zambon S.p.A., Sunovion Pharmaceuticals Inc., Nelson Laboratories LLC, Vectura Group Limited, Abiogen Pharma, Quotient Sciences, AeroGen Pharma, Alaxia S.A.S., Pharmaxis Ltd., Avalyn Pharma Inc., TFF Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the Inhalable Drugs Market?
North America was the largest region in the inhalable drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12490
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respiratory Diseases Propels Growth Of Inhalable Drug Market here
News-ID: 4180394 • Views: …
More Releases from The Business Research Company
Middle Mile Delivery Market Demonstrates Long-Term Growth Potential At 10% CAGR
The middle mile delivery sector is gaining significant attention as global supply chains evolve and demand for efficient logistics solutions grows. With the rise of e-commerce and technological advancements, this market is set for robust expansion in the coming years. Here's an in-depth overview of the middle mile delivery market size, key players, emerging trends, and segmentation insights shaping its future.
Projected Market Size and Growth Trajectory for Middle Mile Delivery…
Maritime Green Corridor Platform Market Outlook Signals Expansion To $3.53 Billi …
The maritime green corridor platform market is set to experience remarkable expansion in the coming years as the shipping industry intensifies its focus on sustainability and emissions reduction. Driven by global environmental goals and technological advancements, this sector is becoming a crucial part of efforts to decarbonize maritime transport and foster greener trade routes. Below is a detailed overview of the market's anticipated growth, leading companies, emerging trends, and segmentation.
Projected…
Marine Tank Cleaning Services Market Report 2026 Market Outlook Supported By A F …
The marine tank cleaning services sector is poised for notable expansion in the coming years, driven by evolving environmental standards and technological advancements. As the shipping industry continues to prioritize sustainability and operational efficiency, this market is set to experience significant growth backed by several key factors. Here's a detailed overview of its current landscape, influential companies, prevailing trends, and segment breakdowns.
Forecasted Market Value and Growth Trajectory in Marine Tank…
Managed Transportation Services Market Insights Highlight Segment Expansion And …
The managed transportation services industry is on the brink of significant expansion as companies increasingly rely on sophisticated logistics solutions. Advancements in technology, coupled with growing demands for efficiency and sustainability, are setting the stage for rapid market growth through 2030. Let's explore the anticipated market size, key players, current trends, and segments that are shaping this evolving market.
Anticipated Growth Trajectory of the Managed Transportation Services Market
The managed…
More Releases for Inhalable
Inhalable Biologics Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Health Coaching Market - By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global inhalable biologics market is estimated to…
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respirat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has seen considerable expansion in the past few years. The market worth, projected to jump from $35.06 billion in 2024 to $37.27 billion in 2025, reflects a compound annual growth…
Inhalable Drugs: Transforming Respiratory Healthcare Delivery
The Business Research Company recently released a comprehensive report on the Global Inhalable Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Inhalable Drugs Market Size, Outlook, Overview 2024-2033
The inhalable drugs market size has grown strongly in recent years. It will grow from $33.29 billion in 2023 to $35.48 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased geriatric population, patient preference for non-invasive treatments, increased focus on respiratory health, emerging markets growth.
The inhalable drugs market size is expected to see strong…
Global Inhalable Drugs Market Size - Forecasts to 2026
As per the research conducted by GME, the Global Inhalable Drugs Market will grow with a CAGR value of 6.8% by 2026. The increasing number of tobacco consumption in the form of smoking among people leads to chronic and acute bronchitis, other pulmonary disorders. Awareness by various governments and campaigns conducted for the treatment of a greater number of people who can’t afford the treatment of lung diseases.
Browse 151 Market…
Inhalable Biologics Market Value Share, Supply Demand, share and Value Chain 201 …
Each year, millions of people are affected by respiratory diseases across the world, due to which, the use of inhalable biologics is also increasing. Inhalable biologics are agents that are formed from the products of living (plant or microorganisms) sources, which are used for treating chronic diseases and acute diseases such as asthma, COPD, and cystic fibrosis, among others. Inhalable biologics are beneficial over the conventional systems because of their…
